RHY
RHYTHM BIOSCIENCES LIMITED
$0.0830
▲ +1.22%
Market cap
$29M
Turnover
$753
Last price
$0.0830
Day change
+1.22%
Announcements
5
Range, past year
Open 0.088 · Low 0.047 · Now 0.083 · High 0.280
Open RHY in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
RHY momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
22/100
Wyckoff phase
Accumulation2d
Trend stage
Neutral
1 Day
+1.2%
1 Week
+1.2%
1 Month
-14.4%
1 Year
-7.8%
RSI
47
Avg daily range
4.7%
RHYTHM BIOSCIENCES LIMITED scores 22 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 2 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -23.8%
- Thin liquidity
- Risk rating: High
- Composite downside risk elevated
RHY announcements
Recent price-sensitive releases.
- 2026-09-22 Initial ColoSTAT Assessment in UK opens new market access Progress Report
- 2026-08-27 FY26 Appendix 4E & Audited Financial Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-30 Quarterly Activities Report and Appendix 4C Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-04-30 Quarterly Activities Report and Appendix 4C
More Health Care stocks
Most traded in the same sector.